AU2005315855A1 - Combination therapy comprising telmisartan and hydrochlorothiazide - Google Patents

Combination therapy comprising telmisartan and hydrochlorothiazide Download PDF

Info

Publication number
AU2005315855A1
AU2005315855A1 AU2005315855A AU2005315855A AU2005315855A1 AU 2005315855 A1 AU2005315855 A1 AU 2005315855A1 AU 2005315855 A AU2005315855 A AU 2005315855A AU 2005315855 A AU2005315855 A AU 2005315855A AU 2005315855 A1 AU2005315855 A1 AU 2005315855A1
Authority
AU
Australia
Prior art keywords
telmisartan
composition
hydrochlorothiazide
angiotensin
receptor antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005315855A
Other languages
English (en)
Inventor
Peter Bohm
Axel Riedel
Helmut E. Schumacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35589356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2005315855(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU2005315855A1 publication Critical patent/AU2005315855A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
AU2005315855A 2004-12-17 2005-12-09 Combination therapy comprising telmisartan and hydrochlorothiazide Abandoned AU2005315855A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63706204P 2004-12-17 2004-12-17
US60/637,062 2004-12-17
PCT/EP2005/013224 WO2006063737A1 (fr) 2004-12-17 2005-12-09 Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide

Publications (1)

Publication Number Publication Date
AU2005315855A1 true AU2005315855A1 (en) 2006-06-22

Family

ID=35589356

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005315855A Abandoned AU2005315855A1 (en) 2004-12-17 2005-12-09 Combination therapy comprising telmisartan and hydrochlorothiazide

Country Status (15)

Country Link
EP (1) EP1827424A1 (fr)
JP (1) JP2008524136A (fr)
KR (1) KR20070097511A (fr)
CN (1) CN101080225A (fr)
AR (1) AR052052A1 (fr)
AU (1) AU2005315855A1 (fr)
BR (1) BRPI0519656A2 (fr)
CA (1) CA2589493A1 (fr)
EA (1) EA200701159A1 (fr)
IL (1) IL183944A0 (fr)
NO (1) NO20072325L (fr)
PE (1) PE20060768A1 (fr)
TW (1) TW200637546A (fr)
UY (1) UY29274A1 (fr)
WO (1) WO2006063737A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
US8637078B2 (en) * 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1970053A1 (fr) * 2007-03-14 2008-09-17 Boehringer Ingelheim Pharma GmbH & Co. KG Composition pharmaceutique
JP4879351B2 (ja) † 2007-10-19 2012-02-22 大塚製薬株式会社 医薬固形製剤
WO2009058950A2 (fr) 2007-10-30 2009-05-07 Dr. Reddy's Laboratories Ltd. Formulations pharmaceutiques comprenant du telmisartan et de l'hydrochlorotiazide
ES2623329T3 (es) 2008-03-19 2017-07-11 Ratiopharm Gmbh Composición farmacéutica sólida que comprende un antagonista no peptídico de receptor de la angiotensina II y un diurético
CN102164918B (zh) * 2008-07-31 2014-05-07 武田药品工业株式会社 固体药物组合物
GB0822170D0 (en) * 2008-12-04 2009-01-14 Arrow Int Ltd Telmisartan with diuretic formulations
EP2443094B1 (fr) 2009-06-19 2013-03-20 Krka Tovarna Zdravil, D.D., Novo Mesto Procédé pour la préparation de telmisartan
EP2448576A2 (fr) * 2009-07-02 2012-05-09 Mahmut Bilgic Composition pharmaceutique augmentant la solubilité
WO2011002425A2 (fr) * 2009-07-02 2011-01-06 Bilgig Mahmut Composition pharmaceutique présentant une solubilité et une stabilité accrues
TR200906506A2 (tr) 2009-08-24 2011-03-21 Bi̇lgi̇ç Mahmut Telmisartan içeren katı dozaj formları.
WO2011161123A2 (fr) 2010-06-21 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Comprimé pharmaceutique multicouche comprenant du telmisartan et un diurétique
EP2952196A4 (fr) * 2013-01-31 2016-08-03 Sawai Seiyaku Kk Comprimé multicouche contenant du telmisartan et de l'hydrochlorothiazide
WO2015012205A1 (fr) * 2013-07-23 2015-01-29 第一三共株式会社 Médicament destiné à la prévention ou au traitement de l'hypertension artérielle
CN106562973A (zh) * 2016-11-06 2017-04-19 成都先先先生物科技有限公司 一种抗高血压药物复方制剂
CN107501192A (zh) * 2017-08-15 2017-12-22 中国科学院上海药物研究所 替米沙坦与氢氯噻嗪的共晶
CN108653227A (zh) * 2018-08-09 2018-10-16 湖北舒邦药业有限公司 一种替米沙坦氢氯噻嗪片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229085C2 (de) * 1992-09-01 1996-07-11 Boehringer Mannheim Gmbh Längliche, teilbare Tablette
MXPA04006997A (es) * 2002-01-16 2004-12-07 Boehringer Ingelheim Pharma Comprimido farmaceutico de dos capas que comprende telmisartan y un diuretico y su preparacion.

Also Published As

Publication number Publication date
JP2008524136A (ja) 2008-07-10
TW200637546A (en) 2006-11-01
KR20070097511A (ko) 2007-10-04
CN101080225A (zh) 2007-11-28
WO2006063737A1 (fr) 2006-06-22
CA2589493A1 (fr) 2006-06-22
EP1827424A1 (fr) 2007-09-05
UY29274A1 (es) 2006-07-31
NO20072325L (no) 2007-07-06
PE20060768A1 (es) 2006-09-29
IL183944A0 (en) 2007-10-31
AR052052A1 (es) 2007-02-28
BRPI0519656A2 (pt) 2009-03-03
EA200701159A1 (ru) 2007-12-28

Similar Documents

Publication Publication Date Title
AU2005315855A1 (en) Combination therapy comprising telmisartan and hydrochlorothiazide
US20060159747A1 (en) Telmisartan and hydrochlorothiazide combination therapy
AU2005300787B2 (en) Bilayer tablet comprising telmisartan and amlodipine
AU2008203182B2 (en) Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
US20050186274A1 (en) Multilayer tablet
US20060078615A1 (en) Bilayer tablet of telmisartan and simvastatin
US20130143937A1 (en) Chlorthalidone combinations
EP2252273B1 (fr) Composition pharmaceutique solide incluant un antagoniste non peptidique du récepteur de l'angiotensine ii et un diurétique
CA2801020A1 (fr) Preparation pharmaceutique stable contenant du telmisartan et de l'hydrochlorothiazide
MX2007007046A (en) Combination therapy comprising telmisartan and hydrochlorothiazide
WO2011027021A1 (fr) Procédé de traitement de l'hypertension
WO2008134047A1 (fr) Procédés de traitement de l'hypertension
WO2010063995A2 (fr) Telmisartan en formulations diurétiques

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period